Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Completed · Phase 2

Conditions studied: Pseudovitellium Detachment, Eye Diseases

In brief

The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control pseudovitelliform detachment.

Key facts

Study ID
NCT00211432
Run by
Manhattan Eye, Ear & Throat Hospital
People needed
4
Starts
2008-04-01
Expected to finish
2010-04-01
Last updated by the study team
2012-10-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.